David M. Denton's most recent trade in Pfizer Inc. was a trade of 413,138 Stock Appreciation Rights done . Disclosure was reported to the exchange on March 4, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer Inc. | David M. Denton | Chief Financial Officer & EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 413,138 | 413,138 | - | - | Stock Appreciation Rights | |
| Pfizer Inc. | David M. Denton | Chief Financial Officer & EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 103,320 | 103,320 | - | - | Stock Appreciation Rights | |
| Pfizer Inc. | David M. Denton | Chief Financial Officer & EVP | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Sep 2024 | 103,320 | 0 | - | - | Stock Appreciation Rights | |
| Pfizer Inc. | David M. Denton | Chief Financial Officer & EVP | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Sep 2024 | 80,703 | 0 | - | - | Stock Appreciation Rights | |
| Pfizer Inc. | David M. Denton | Chief Financial Officer & EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2024 | 80,703 | 80,703 | - | - | Stock Appreciation Rights | |
| Pfizer Inc. | David M. Denton | Chief Financial Officer & EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.66 per share. | 31 May 2024 | 12,107 | 37,919 (0%) | 0% | 28.7 | 346,987 | Common Stock |
| Pfizer Inc. | Denton David M. | Chief Financial Officer & EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 161,160 | 161,160 | - | - | Stock Appreciation Rights | |
| Pfizer Inc. | Denton David M. | Chief Financial Officer & EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 142,400 | 142,400 | - | - | Stock Appreciation Rights | |
| Pfizer Inc. | David M. Denton | Chief Financial Officer & EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.02 per share. | 31 May 2023 | 16,223 | 48,224 (0%) | 0% | 38.0 | 616,798 | Common Stock |
| Pfizer Inc. | David M. Denton | Chief Financial Officer & EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 103,320 | 103,320 | - | - | Stock Appreciation Rights | |
| Pfizer Inc. | David M. Denton | Chief Financial Officer & EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 89,920 | 89,920 | - | - | Stock Appreciation Rights | |
| Tapestry Inc | David M. Denton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2022 | 6,822 | 6,822 | - | - | Stock Option | |
| Tapestry Inc | David M. Denton | Director | Grant, award, or other acquisition of securities at price $ 34.98 per share. | 15 Nov 2022 | 2,430 | 37,647 (0%) | 0% | 35.0 | 85,001 | Common Stock |
| Pfizer Inc. | David M. Denton | Chief Financial Officer & EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2022 | 80,703 | 80,703 | - | - | Stock Appreciation Rights | |
| Pfizer Inc. | David M. Denton | Chief Financial Officer & EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2022 | 70,313 | 70,313 | - | - | Stock Appreciation Rights | |
| Pfizer Inc. | David M. Denton | Chief Financial Officer & EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2022 | 61,275 | 62,165 (0%) | 0% | 0 | Common Stock | |
| Lowe`s Cos., Inc. | David M. Denton | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2022 | 38,220 | 72,543 (0%) | 0% | 0 | Common Stock | |
| Lowe`s Cos., Inc. | David M. Denton | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2022 | 38,220 | 0 | - | - | Performance Share Units | |
| Lowe`s Cos., Inc. | David M. Denton | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 202.40 per share. | 01 Apr 2022 | 21,230 | 51,313 (0%) | 0% | 202.4 | 4,296,952 | Common Stock |
| Lowe`s Cos., Inc. | David M. Denton | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 18,265 | 18,265 | - | - | Non-Qualified Stock Option (right to buy) | |
| Lowe`s Cos., Inc. | David M. Denton | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 5,350 | 56,663 (0%) | 0% | 0 | Common Stock | |
| Lowe`s Cos., Inc. | David M. Denton | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2022 | 38,220 | 38,220 | - | - | Performance Share Units | |
| Lowe`s Cos., Inc. | David M. Denton | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 258.48 per share. | 02 Jan 2022 | 3,737 | 34,323 (0%) | 0% | 258.5 | 965,940 | Common Stock |
| Tapestry Inc | David M. Denton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2021 | 5,523 | 5,523 | - | - | Stock Option | |
| Tapestry Inc | David M. Denton | Director | Grant, award, or other acquisition of securities at price $ 41.82 per share. | 03 Nov 2021 | 1,793 | 35,162 (0%) | 0% | 41.8 | 74,983 | Common Stock |
| Lowe`s Cos., Inc. | David M. Denton | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 21,593 | 21,593 | - | - | Non-Qualified Stock Option (right to buy) | |
| Lowe`s Cos., Inc. | David M. Denton | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 5,660 | 38,060 (0%) | 0% | 0 | Common Stock | |
| Tapestry Inc | David M. Denton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Nov 2020 | 7,282 | 7,282 | - | - | Stock Option | |
| Tapestry Inc | David M. Denton | Director | Grant, award, or other acquisition of securities at price $ 24.71 per share. | 05 Nov 2020 | 3,035 | 33,350 (0%) | 0% | 24.7 | 74,995 | Common Stock |